PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
4.560
-0.100 (-2.15%)
Nov 3, 2025, 3:40 PM EST - Market open
PepGen Employees
PepGen had 81 employees as of December 31, 2024. The number of employees increased by 17 or 26.56% compared to the previous year.
Employees
81
Change (1Y)
17
Growth (1Y)
26.56%
Revenue / Employee
n/a
Profits / Employee
-$1,196,481
Market Cap
313.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Dec 31, 2023 | 64 | 19 | 42.22% |
| Dec 31, 2022 | 45 | 14 | 45.16% |
| Dec 31, 2021 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PEPG News
- 8 hours ago - PepGen to Participate in Upcoming Investor Conferences - Business Wire
- 26 days ago - PepGen: DMD Discontinued, Ways To Go With DM1 - Seeking Alpha
- 4 weeks ago - PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire
- 5 weeks ago - PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 5 weeks ago - PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles - Benzinga
- 5 weeks ago - PepGen Announces Pricing of $100 Million Public Offering - Business Wire
- 5 weeks ago - PepGen Announces Proposed Public Offering - Business Wire
- 5 weeks ago - PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients - Business Wire